Devyser Diagnostics AB (DVYSR) — Capital Reinvestment Ratio
Devyser Diagnostics AB (DVYSR) has a Capital Reinvestment Ratio of 0.02x as of March 2026, meaning it reinvests 0% of its operating cash flow (Skr12.10 Million) in capital expenditures (Skr300.00K). See DVYSR equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Devyser Diagnostics AB Capital Reinvestment Ratio (2018–2025)
This chart tracks Devyser Diagnostics AB's Capital Reinvestment Ratio across 4 annual periods. Check cash flow reinvestment rate of Devyser Diagnostics AB to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Devyser Diagnostics AB (2018–2025)
Year-by-year Capital Reinvestment Ratio for Devyser Diagnostics AB from 2018 to 2025. For live market cap and broader valuation context, see Devyser Diagnostics AB market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | Skr8.20 Million | Skr1.50 Million | ▼ -96.6% |
| 2020 | 5.44x | Skr627.00K | Skr3.41 Million | ▲ +755.5% |
| 2019 | 0.64x | Skr14.63 Million | Skr9.31 Million | ▼ -24.3% |
| 2018 | 0.84x | Skr6.02 Million | Skr5.06 Million | — |